Tactile Systems Technology, Inc. (TCMD) Q2 2023 Earnings Call Transcript

SA Transcripts
153.96K Followers

Q2: 2023-08-07 Earnings Summary

EPS of $0.04 beats by $0.07
 | Revenue of $68.34M (14.58% Y/Y) beats by $3.05M

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET

Company Participants

Daniel Reuvers - President & Chief Executive Officer
Elaine Birkemeyer - Chief Financial Officer

Conference Call Participants

Simran Kaur - Piper Sandler
Margaret Kaczor - William Blair & Company
Suraj Kalia - Oppenheimer & Co. Inc.

Operator

Welcome, ladies and gentlemen, to the Second Quarter of Fiscal Year 2023 Earnings Conference Call for Tactile Medical. [Operator Instructions] Please note that this conference call is being recorded and will be available on the company's website for replay shortly.

Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties which could cause actual results to differ materially from those indicated, including those identified in the Risk Factors section of our annual report on Form 10-K as well as our most recent 10-Q filing to be filed with the Securities and Exchange Commission. Such factors may be updated from time to time in our filings with the SEC which are available on our website. We undertake no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise. This call will also include references to certain financial measures that are not calculated in accordance with generally accepted accounting principles, or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings press release on the Investor Relations portion of our website.

I would now like to turn the call over to Mr. Dan Reuvers, Tactile Medical's President and Chief Executive

Recommended For You

About TCMD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on TCMD